Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E<sub>2</sub> Activation in Human Podocytes

Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E<sub>2</sub> Activation in Human Podocytes

Glomerular hyperfiltration is an important mechanism in the development of albuminuria. During hyperfiltration, podocytes are exposed to increased fluid flow shear stress (FFSS) in Bowman’s space. Elevated Prostaglandin E2 (PGE<sub>2</sub>) synthesis and upregulated cyclooxygenase 2 (Cox...

Full description

Bibliographic Details
Main Authors:	Eva Mangelsen, Michael Rothe, Angela Schulz, Aikaterini Kourpa, Daniela Panáková, Reinhold Kreutz, Juliane Bolbrinker
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Cells
Subjects:	podocyte hyperfiltration chronic kidney disease prostaglandin E2 COX2 EP2
Online Access:	https://www.mdpi.com/2073-4409/9/5/1256

Similar Items

Tissue lipidomic profiling supports a mechanistic role of the prostaglandin E2 pathway for albuminuria development in glomerular hyperfiltration
by: Debora Kaiser-Graf, et al.
Published: (2023-12-01)

EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth
by: Jing-cai Niu, et al.
Published: (2019-08-01)

Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists
by: Johanna Bödder, et al.
Published: (2023-01-01)

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
by: Anna Semmlinger, et al.
Published: (2018-04-01)

Immunolocalization of Prostaglandin E2 Receptor Subtype 4 (EP4) in the Cervix of Cyclic Bitches and Those with Pyometra
by: P Linharattanaruksa1, K Chatdarong1, S Ponglowhapan1, M Khalid3 and S Srisuwatanasagul2*
Published: (2013-07-01)

PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer
by: Behnia Akbari, et al.
Published: (2023-06-01)

QSAR and docking based lead optimization of nitrogen heterocycles for enhanced prostaglandin EP2 receptor agonistic potency
by: Rahul D Jawarkar, et al.
Published: (2024-06-01)

Human Amniotic Membrane Mesenchymal Stem Cell-Synthesized PGE<sub>2</sub> Exerts an Immunomodulatory Effect on Neutrophil Extracellular Trap in a PAD-4-Dependent Pathway through EP2 and EP4
by: Gibrán Alejandro Estúa-Acosta, et al.
Published: (2022-09-01)

Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
by: ZHENG Lirong, et al.
Published: (2023-09-01)

EP2 inhibition restores myeloid metabolism and reverses cognitive decline
by: Ryan Lushington, MS, et al.
Published: (2023-05-01)

Inhibition of rat locus coeruleus neurons by prostaglandin E2 EP3 receptors: pharmacological characterization ex vivo
by: Amaia Nazabal, et al.
Published: (2023-11-01)

Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure
by: Lu Wang, et al.
Published: (2022-06-01)

Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E₂ receptor EP4
by: Yu Ah Hong, et al.
Published: (2017-06-01)

Stimulation of gastroduodenal HCO3- secretion by lubiprostone mediated by different prostaglandin EP receptor subtypes
by: Koji Takeuchi, et al.
Published: (2020-06-01)

Gene expression of prostaglandin EP4 receptor in three canine carcinomas
by: Margaret L. Musser, et al.
Published: (2020-06-01)

PGE2 inhibits neutrophil phagocytosis through the EP2R–cAMP–PTEN pathway
by: Zixuan Wang, et al.
Published: (2022-07-01)

EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
by: Alaleh Zati Zehni, et al.
Published: (2020-06-01)

Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
by: Ana Carolina Furlanetto Mançanares, et al.
Published: (2020-06-01)

Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy
by: Mc Millan Ching, et al.
Published: (2020-05-01)

Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules
by: Ward Vleeshouwers, et al.
Published: (2021-02-01)

Synergistic Cytokine Production by ATP and PGE<sub>2</sub> via P2X4 and EP<sub>3</sub> Receptors in Mouse Bone-Marrow-Derived Mast Cells
by: Kosuke Obayashi, et al.
Published: (2022-02-01)

A Phytoprostane from <i>Gracilaria longissima</i> Increases Platelet Activation, Platelet Adhesion to Leukocytes and Endothelial Cell Migration by Potential Binding to EP3 Prostaglandin Receptor
by: Silvia Montoro-García, et al.
Published: (2023-02-01)

Spatial and temporal changes in the PGE2 EP2 receptor in mice hippocampi during postnatal development and its relationship with cyclooxygenase-2
by: Hyo Young Jung, et al.
Published: (2021-07-01)

Prostaglandin EP4 Selective Agonist AKDS001 Enhances New Bone Formation by Minimodeling in a Rat Heterotopic Xenograft Model of Human Bone
by: Yuichiro Ukon, et al.
Published: (2022-03-01)

The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus
by: Asheebo Rojas, et al.
Published: (2014-10-01)

Screening and identification of dietary oils and unsaturated fatty acids in inhibiting inflammatory prostaglandin E<sub>2</sub> signaling in fat stromal cells
by: Ruan Diana, et al.
Published: (2012-08-01)

Calcium Ions Stimulate the Hyperphosphorylation of Tau by Activating Microsomal Prostaglandin E Synthase 1
by: Long-Long Cao, et al.
Published: (2019-05-01)

Prostaglandin E2 and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: No impact on survival of seizure-generated neurons
by: Maria Antonietta Ajmone-Cat, et al.
Published: (2006-07-01)

Pharmacological modulation of prostaglandin E2 (PGE2) EP receptors improves cardiomyocyte function under hyperglycemic conditions
by: Karin J. Bosma, et al.
Published: (2022-04-01)

Differential roles of prostaglandin E2 EP4 receptor on stromal cell populations for hematopoietic stem and progenitor cell function
by: Liqiong Liu, et al.
Published: (2023-11-01)

PROSTAGLANDIN Е<sub>2</sub> AS GULL TAPEWORM POTENTiAL iMMUNOMODULATOR
by: I. A. Kutyrev, et al.
Published: (2012-09-01)

Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
by: Federica Finetti, et al.
Published: (2020-12-01)

Prostaglandin E2 induced cardiac hypertrophy through EP2 receptor‐dependent activation of β‐catenin in 5/6 nephrectomy rats
by: Yaqiong Wang, et al.
Published: (2021-06-01)

Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats
by: Blesson Chellakkan S, et al.
Published: (2012-01-01)

The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies
by: Tijana Markovič, et al.
Published: (2022-01-01)

Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor Agonists
by: Najam A. Sharif, et al.
Published: (2024-03-01)

Cell‐Specific Actions of the Prostaglandin E‐Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages
by: Ting Yang, et al.
Published: (2022-10-01)

Intrauterine devices influence prostaglandin secretion by equine uterus: in vitro and in vivo studies
by: Katarzyna Karolina Piotrowska-Tomala, et al.
Published: (2024-02-01)

Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke
by: Kelly M. DeMars, et al.
Published: (2018-02-01)

A Representative GIIA Phospholipase A<sub>2</sub> Activates Preadipocytes to Produce Inflammatory Mediators Implicated in Obesity Development
by: Elbio Leiguez, et al.
Published: (2020-11-01)